Family history of prostate cancer in patients with localized prostate cancer: An independent predictor of treatment outcome

Journal of Clinical Oncology

Volumn 15, Issue 4, 1997, Pages 1478-1480

  Kupelian, P A ^a   Kupelian, V A ^a   Witte, J S ^a   Macklis, R ^a   Klein, E A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME;

EID: 0030936748     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.4.1478     Document Type: Article

References (14)

1. Carter B, Beaty T, Steinberg G, et al: Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89:3367-3371, 1992
2. Carter B, Bova G, Beaty T, et al: Hereditary prostate cancer: Epidemiologic and clinical features. J Urol 150:797-802, 1993
3. Spitz M, Currier R, Fueger J, et al: Familial patterns of prostate cancer: A case-control analysis. J Urol 146:1305-1307, 1991
4. Woolf C: An investigation of the familial aspects of carcinoma of the prostate. Cancer 13:739-744, 1960
5. Bova G, Isaacs S, Partin A, et al: Biological aggressiveness of hereditary prostate cancer: Long term evaluation following radical prostatectomy. J Urol 153:505A, 1995 (abstr)
6. Bastacky S, Wojno K, Walsh P, et al: Pathological features of hereditary prostate cancer. J Urol 153:987-992, 1995
7. Partin A, Pound C, Clemens J, et al: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 20:713-725, 1993
8. Zagars G, von Eschenbach A: Prognostic factors in prostate cancer: Prostate specific antigen: An important marker for prostate cancer treated by external beam radiotherapy. Cancer 72:538-548, 1993
9. Zagars G, Pollack A: Radiation therapy for T1 and T2 prostate cancer: Prostatic-specific antigen and disease outcome. Urology 45:476-483, 1995
10. Harris E, Albert A: Survivorship Analysis for Clinical Studies. New York, NY, Marcel Dekker, 1991
11. Kupelian P, Levin H, Zippe C, et al: External beam radiotherapy versus radical prostatectomy for localized prostate cancer: A single institution experience. J Urol 155:556A, 1996 (abstr)
12. Kupelian P, Katcher J, Levin H, et al: Correlation of clinical and pathologic factors with rising PSA profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology 48:249-260, 1996
13. Stein A, deKernion J, Smith R, et al: Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. J Urol 147:942-946, 1992
14. Partin A, Yoo J, Carter H, et al: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150:110-114, 1993